No article has been written about this topic yet.
Paste a URL about this topic to auto-extract knowledge.
Visit our Writing Guide for help on how to write about a topic,
and check out an example of a well filled out topic page.
No article has been written about this topic yet.
Be the first one to add some text.
Loading AI-assisted edit mode...
Timeline
April 2019
SpringWorks Therapeutics raises a $125,000,000 series B round from Laurion Capital Management, LifeArc, Samsara BioCapital, ArrowMark Partners, Tavistock Group, Surveyor Capital, GlaxoSmithKline, Biotechnology Value Fund, OrbiMed, Pfizer Ventures and HBM Healthcare Investments AG.
September 2017
SpringWorks Therapeutics raises a $103,000,000 series A round from Bain Capital Double Impact, LifeArc, Bain Capital Life Sciences, Pfizer and OrbiMed.
Funding rounds
Funding round
Funding round amount (USD)
Funding type
Funding round date
Investment
125,000,000
Series B roundApril 2019
HBM Healthcare Investments AG
Tavistock Group
Biotechnology Value Fund (BVF Partners)
Surveyor Capital
Samsara BioCapital
ArrowMark Partners
GlaxoSmithKline
Laurion Capital Management
OrbiMed
Pfizer Ventures
LifeArc
Series A round
Bain Capital Life Sciences
Bain Capital Double Impact
PfizerPeople
Name
Role
LinkedIn
+ Add new row
Further reading
Title
Author
Link
Type
Date
+ Add new row
Documentaries, videos and podcasts
Title
Date
Link
+ Add new row
Companies
Company
CEO
Location
Products/Services
+ Add new row
SpringWorks Therapeutics
Is a
CompanyCompany attributes
Industry
Biotechnology
Durham, North Carolina
Stamford, ConnecticutLegal name
SpringWorks Therapeutics, LLC
Crunchbase
Total funding amount (USD)
228,000,000
Other attributes
Headquarters
